PL2198042T3 - Nowe markery do wykrywania raka pęcherza moczowego - Google Patents

Nowe markery do wykrywania raka pęcherza moczowego

Info

Publication number
PL2198042T3
PL2198042T3 PL08802026T PL08802026T PL2198042T3 PL 2198042 T3 PL2198042 T3 PL 2198042T3 PL 08802026 T PL08802026 T PL 08802026T PL 08802026 T PL08802026 T PL 08802026T PL 2198042 T3 PL2198042 T3 PL 2198042T3
Authority
PL
Poland
Prior art keywords
bladder cancer
cancer detection
novel markers
markers
novel
Prior art date
Application number
PL08802026T
Other languages
English (en)
Inventor
Isabelle Renard
Criekinge Wim Van
Original Assignee
Mdxhealth Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/GB2008/002093 external-priority patent/WO2008155549A2/en
Application filed by Mdxhealth Sa filed Critical Mdxhealth Sa
Publication of PL2198042T3 publication Critical patent/PL2198042T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Analytical Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Pathology (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
PL08802026T 2007-09-17 2008-09-11 Nowe markery do wykrywania raka pęcherza moczowego PL2198042T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US96012907P 2007-09-17 2007-09-17
US7197108P 2008-05-28 2008-05-28
PCT/GB2008/002093 WO2008155549A2 (en) 2007-06-19 2008-06-19 Improved urine sample collecting and processing

Publications (1)

Publication Number Publication Date
PL2198042T3 true PL2198042T3 (pl) 2017-05-31

Family

ID=39945563

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08802026T PL2198042T3 (pl) 2007-09-17 2008-09-11 Nowe markery do wykrywania raka pęcherza moczowego

Country Status (8)

Country Link
US (2) US9322065B2 (pl)
EP (2) EP2198042B1 (pl)
JP (2) JP5697448B2 (pl)
CA (1) CA2699606C (pl)
DK (1) DK2198042T3 (pl)
ES (1) ES2605237T3 (pl)
PL (1) PL2198042T3 (pl)
WO (1) WO2009036922A2 (pl)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101353695B (zh) * 2007-07-23 2013-05-01 上海市肿瘤研究所 尿沉淀dna甲基化谱式分析诊断膀胱癌的方法和试剂盒
EP2198042B1 (en) * 2007-09-17 2016-11-02 MDxHealth SA Novel markers for bladder cancer detection
WO2010102823A1 (en) * 2009-03-13 2010-09-16 Oncomethylome Sciences Sa Novel markers for bladder cancer detection
CN102292458A (zh) * 2009-04-03 2011-12-21 A&T株式会社 大肠肿瘤的检测方法
EP3620532B1 (en) * 2009-04-20 2021-12-22 Erasmus University Medical Center Rotterdam Method of diagnosing bladder cancer
EP2446055A1 (en) * 2009-06-26 2012-05-02 Epigenomics AG Methods and nucleic acids for analysis of bladder cell proliferative disorders
US9783850B2 (en) 2010-02-19 2017-10-10 Nucleix Identification of source of DNA samples
US9752187B2 (en) 2009-12-11 2017-09-05 Nucleix Categorization of DNA samples
WO2011104731A1 (en) * 2010-02-26 2011-09-01 Decode Genetics Ehf Genetic variants as markers for use in urinary bladder cancer risk assessment, diagnosis, prognosis and treatment
WO2011112880A2 (en) * 2010-03-12 2011-09-15 The Johns Hopkins University Hypermethylation biomarkers for detection of head and neck squamous cell cancer
US20130041047A1 (en) * 2011-06-01 2013-02-14 Aros Applied Biotechnology As Urinary Methylation Markers for Bladder Cancer
WO2015035415A1 (en) 2013-09-09 2015-03-12 Nantomics, Llc Method of detecting suceptibility to breast cancer through mutations in the fgfr3 and tp53 genes
US10689652B2 (en) 2013-10-02 2020-06-23 The Regents Of The University Of California Methods for immortalization of epithelial cells
US9476100B1 (en) * 2015-07-06 2016-10-25 Nucleix Ltd. Methods for diagnosing bladder cancer
DE102015009187B3 (de) 2015-07-16 2016-10-13 Dimo Dietrich Verfahren zur Bestimmung einer Mutation in genomischer DNA, Verwendung des Verfahrens und Kit zur Durchführung des Verfahrens
WO2017062517A1 (en) * 2015-10-06 2017-04-13 The Regents Of The University Of California Non-coding rnas linked to immortality and associated methods and compositions
EP3359696A4 (en) * 2015-10-08 2019-09-25 Convergent Genomics, Inc. DIAGNOSTIC TEST FOR URINE MONITORING OF BUBBLE CANCER
RU2612139C1 (ru) * 2015-12-29 2017-03-02 Федеральное государственное бюджетное учреждение науки институт биоорганической химии им. академиков М.М. Шемякина и Ю.А. Овчинникова Российской академии наук (ИБХ РАН) Набор синтетических олигонуклеотидов для определения уровней экспрессии гена pdlim4
KR20180129878A (ko) 2016-04-01 2018-12-05 나노메드 디아그노스틱스 비브이 소변에서 암의 검출
WO2018047883A1 (ja) * 2016-09-06 2018-03-15 株式会社ユカシカド スポット尿を用いたヘルスケアシステム
US20190352721A1 (en) 2016-09-29 2019-11-21 Hanumat Co., Ltd. Method for determining likelihood of sporadic colorectal cancer development
CN107014658B (zh) * 2017-05-27 2023-08-25 四川省肿瘤医院 提取游离细胞的方法及试剂盒
JP2020535789A (ja) * 2017-08-02 2020-12-10 ザルシュテット・アーゲー・ウント・コー・カーゲー 無細胞核酸及び細胞を安定化するための方法及び組成物
US20210172029A1 (en) * 2018-07-11 2021-06-10 Stichting Vumc Urine dna methylation markers for bladder cancer
IL265451B (en) 2019-03-18 2020-01-30 Frumkin Dan Methods and systems for the detection of methylation changes in DNA samples
KR102186534B1 (ko) * 2019-04-11 2020-12-03 차의과학대학교 산학협력단 수지상세포의 성숙도 측정 방법 및 조성물, 그리고 이의 용도
CN110283914A (zh) * 2019-07-29 2019-09-27 上海透景生命科技股份有限公司 一种膀胱癌的新型基因诊断试剂盒及其应用
CN113943799B (zh) * 2020-07-16 2023-12-15 广州达健生物科技有限公司 用于检测膀胱癌的组合物及其试剂盒和应用
CN113957160B (zh) * 2020-07-20 2024-03-29 深圳华大生命科学研究院 检测膀胱癌的标志物及检测该标志物的引物对及其应用
CN115094139B (zh) * 2022-06-22 2023-04-28 武汉艾米森生命科技有限公司 检测甲基化水平的试剂在制备膀胱癌诊断产品中的应用以及膀胱癌诊断试剂盒
CN116004831A (zh) * 2023-01-05 2023-04-25 武汉艾米森生命科技有限公司 一种用于膀胱癌的诊断或辅助诊断的试剂及检测试剂盒

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4437975A (en) 1977-07-20 1984-03-20 Mobil Oil Corporation Manufacture of lube base stock oil
CA1340843C (en) 1987-07-31 1999-12-07 J. Lawrence Burg Selective amplification of target polynucleotide sequences
AU4829690A (en) 1988-12-16 1990-07-10 Siska Diagnostics, Inc. Self-sustained, sequence replication system
US6017704A (en) 1996-06-03 2000-01-25 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
GB9710995D0 (en) * 1997-05-28 1997-07-23 Marie Curie Research Inst Tumour suppressor locus and gene at 9q32-33
WO2000023112A1 (en) * 1998-10-19 2000-04-27 Methylgene, Inc. Modulation of gene expression by combination therapy
KR100475649B1 (ko) 2001-01-29 2005-03-10 배석철 항암활성을 나타내는 ｒｕｎｘ３ 유전자 및 그의 용도
AU2002359436A1 (en) 2001-11-13 2003-06-23 Rubicon Genomics Inc. Dna amplification and sequencing using dna molecules generated by random fragmentation
WO2004067726A2 (en) 2003-01-29 2004-08-12 Keck Graduate Institute Isothermal reactions for the amplification of oligonucleotides
EP1604040B1 (en) 2003-03-07 2010-10-13 Rubicon Genomics, Inc. Amplification and analysis of whole genome and whole transcriptome libraries generated by a dna polymerization process
US20040209299A1 (en) 2003-03-07 2004-10-21 Rubicon Genomics, Inc. In vitro DNA immortalization and whole genome amplification using libraries generated from randomly fragmented DNA
US8062849B2 (en) * 2003-10-28 2011-11-22 The Johns Hopkins University Quantitative multiplex methylation-specific PCR
JP4590893B2 (ja) 2004-03-23 2010-12-01 Ｊｓｒ株式会社 接着剤用液状硬化性樹脂組成物
US8110361B2 (en) * 2005-05-02 2012-02-07 University of Southern California USC Stevens Center for Innovation DNA methylation markers associated with the CpG island methylator phenotype (CIMP) in human colorectal cancer
WO2006135886A2 (en) * 2005-06-13 2006-12-21 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
EP1960551A2 (en) * 2005-12-01 2008-08-27 Medical Prognosis Institute Methods and devices for identifying biomarkers of treatment response and use thereof to predict treatment efficacy
WO2007116417A1 (en) 2006-04-07 2007-10-18 Silvia Sabbioni Novel dna methylation markers useful for the diagnosis of neoplastic diseases
WO2008155549A2 (en) 2007-06-19 2008-12-24 Oncomethylome Sciences Sa Improved urine sample collecting and processing
EP2198042B1 (en) * 2007-09-17 2016-11-02 MDxHealth SA Novel markers for bladder cancer detection

Also Published As

Publication number Publication date
WO2009036922A2 (en) 2009-03-26
ES2605237T3 (es) 2017-03-13
CA2699606A1 (en) 2009-03-26
DK2198042T3 (en) 2017-01-23
JP2015051006A (ja) 2015-03-19
US10113202B2 (en) 2018-10-30
JP2010538624A (ja) 2010-12-16
EP2198042B1 (en) 2016-11-02
US20160208341A1 (en) 2016-07-21
EP2198042A2 (en) 2010-06-23
CA2699606C (en) 2023-04-11
EP3147375A1 (en) 2017-03-29
US9322065B2 (en) 2016-04-26
JP5697448B2 (ja) 2015-04-08
WO2009036922A3 (en) 2009-05-28
US20100280134A1 (en) 2010-11-04

Similar Documents

Publication Publication Date Title
PL2198042T3 (pl) Nowe markery do wykrywania raka pęcherza moczowego
HK1212245A1 (en) Molecular marker for cancer stem cell
PL2456889T3 (pl) Markery diagnostyczne raka błony śluzowej trzonu macicy
EP2171453A4 (en) OVARIAN CANCER-FORECAST MARKER
EP2079132A4 (en) SECTOR ANTENNA
IL190382A0 (en) Detecting prostate cancer
EP2115162A4 (en) ADRB2-CANCER MARKER
IL227562A (en) Symptoms of breast cancer
GB0717101D0 (en) Tumour marker
ZA200907678B (en) Polynucleotide markers
EP2147298A4 (en) PROOF OF CANCER MARKERS
GB0707933D0 (en) Disease markers
GB0724412D0 (en) Marker
AU320441S (en) Marker
EP2240886A4 (en) FLASH DETECTION
EP2252706A4 (en) SLIT2-CANCER MARKER
EP2155250A4 (en) CANCER PAN MARKER CONTAINING CARBON HYDRATE
EP2486154A4 (en) DIAGNOSTIC AND PROGNOSTIC MARKERS FOR CANCER
ZA200900606B (en) Markers for pigmentation
PT2356252E (pt) Método para a deteção urinária do cancro da bexiga
GB0809689D0 (en) Markers for prostate cancee
EP2283148A4 (en) CYTOLOGICAL METHODS FOR CANCER SCREENING
GB0707671D0 (en) Fiducial marker
GB0718496D0 (en) Markers
EP2187216A4 (en) NEW LIVER CANCER MARKER